Teva Pharmaceutical
TEVA
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
24/7 Wall Street • 1 day ago • TEVA
Teva Crushes Earnings as Pfizer Struggles to Replace COVID Revenue
Seeking Alpha • 2 days ago • TEVA
Teva Pharmaceutical Industries Limited (TEVA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Zacks Investment Research • 5 days ago • TEVA
Why Teva Pharmaceutical Industries Ltd. (TEVA) is a Top Value Stock for the Long-Term
The Motley Fool • 7 days ago • TEVA
30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech Stocks
GlobeNewsWire • 12 days ago • TEVA
Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva®
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.